The Vanguard Group 13D and 13G filings for AngioDynamics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 4:58 pm Sale |
2023-12-29 | 13G | AngioDynamics, Inc. ANGO |
The Vanguard Group | 2,268,461 5.690% |
-513,332 (-18.45%) |
Filing |
| 2023-02-09 11:07 am Purchase |
2022-12-30 | 13G | AngioDynamics, Inc. ANGO |
The Vanguard Group | 2,781,793 7.110% |
220,569 (+8.61%) |
Filing |
| 2022-02-09 3:24 pm Purchase |
2021-12-31 | 13G | AngioDynamics, Inc. ANGO |
The Vanguard Group | 2,561,224 6.630% |
330,101 (+14.80%) |
Filing |
| 2021-02-10 10:30 am Sale |
2020-12-31 | 13G | AngioDynamics, Inc. ANGO |
The Vanguard Group | 2,231,123 5.880% |
-139,576 (-5.89%) |
Filing |